City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Smita Bhatia, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 08218 ClinicalTrials.gov Number: NCT01196936

Principal Investigator: Smita Bhatia, MD
Sponsor: NCI Approved External Peer Review

Title:  Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial

COH Protocol Number: 08065

Principal Investigator: Smita Bhatia, MD
Sponsor: Cooperative Group

Title:  COG ALTE05N1: Umbrella Long Term Follow Up Protocol

COH Protocol Number: 01115

Principal Investigator: Smita Bhatia, MD
Sponsor: Institutional

Title:  Long Term Follow-up Clinic for Survivors of Childhood Cancer

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.